GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » PB Ratio

Actinogen Medical (ASX:ACW) PB Ratio : 5.60 (As of May. 23, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-23), Actinogen Medical's share price is A$0.028. Actinogen Medical's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.01. Hence, Actinogen Medical's PB Ratio of today is 5.60.

The historical rank and industry rank for Actinogen Medical's PB Ratio or its related term are showing as below:

ASX:ACW' s PB Ratio Range Over the Past 10 Years
Min: 0.93   Med: 6.63   Max: 24.36
Current: 5.4

During the past 13 years, Actinogen Medical's highest PB Ratio was 24.36. The lowest was 0.93. And the median was 6.63.

ASX:ACW's PB Ratio is ranked worse than
75.4% of 1313 companies
in the Biotechnology industry
Industry Median: 2.54 vs ASX:ACW: 5.40

During the past 12 months, Actinogen Medical's average Book Value Per Share Growth Rate was -37.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -8.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -12.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 3.70% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Actinogen Medical was 51.80% per year. The lowest was -56.00% per year. And the median was -12.80% per year.

Back to Basics: PB Ratio


Actinogen Medical PB Ratio Historical Data

The historical data trend for Actinogen Medical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical PB Ratio Chart

Actinogen Medical Annual Data
Trend Jun13 Jun14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 2.27 12.32 4.31 5.41

Actinogen Medical Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.66 4.31 11.84 5.41 4.34

Competitive Comparison of Actinogen Medical's PB Ratio

For the Biotechnology subindustry, Actinogen Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actinogen Medical's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's PB Ratio distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's PB Ratio falls into.



Actinogen Medical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Actinogen Medical's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.028/0.005
=5.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Actinogen Medical  (ASX:ACW) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Actinogen Medical PB Ratio Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Actinogen Medical (ASX:ACW) Business Description

Traded in Other Exchanges
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.

Actinogen Medical (ASX:ACW) Headlines

From GuruFocus

Stocks That Are Making A Good Come Back

By reports.droy reports.droy 03-10-2015

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish 10-13-2014